HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasminogen activator inhibitor type 1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via alpha(v)beta(5) integrin.

Abstract
Both urokinase plasminogen activator (u-PA) and plasminogen activator inhibitor type 1 (PAI-1) are associated with a poor prognosis in cancer patients. We demonstrate that PAI-1 inhibits human fibrosarcoma cell (HT-1080) adhesion to vitronectin (Vn) via alpha (v)beta (5) integrin, and stimulates cell migration from Vn toward collagen type IV (Col). The cells attached more strongly to Vn and Col than to fibronectin (Fn), whereas PAI-1 interfered with cell attachment to Vn only. An integrin antagonist, RGD peptide, and anti-alpha (v)beta (5) integrin antibodies, which similarly inhibited cell attachment to Vn, also stimulated cell migration from Vn toward Col. u-PA did not modify cell attachment directly, but reversed the PAI-1-mediated inhibitory effect on cell adhesion to Vn, and its stimulatory effect on cell migration from Vn toward Col. Thus HT-1080 cell migration appears to be modified by u-PA and PAI-1, altering cell adhesion to Vn via alpha (v)beta (5) integrin. This may be related to their tumor-promoting effect.
AuthorsTsuyoshi Takahashi, Kazuya Suzuki, Hayato Ihara, Hideo Mogami, Teruhisa Kazui, Tetsumei Urano
JournalSeminars in thrombosis and hemostasis (Semin Thromb Hemost) Vol. 31 Issue 3 Pg. 356-63 (Jun 2005) ISSN: 0094-6176 [Print] United States
PMID16052409 (Publication Type: Journal Article)
Chemical References
  • Collagen Type IV
  • Fibronectins
  • Integrins
  • Plasminogen Activator Inhibitor 1
  • Receptors, Vitronectin
  • Vitronectin
  • integrin alphaVbeta5
  • Urokinase-Type Plasminogen Activator
Topics
  • Cell Adhesion
  • Cell Line, Tumor
  • Cell Movement
  • Collagen Type IV (metabolism)
  • Fibronectins (metabolism)
  • Fibrosarcoma (pathology)
  • Humans
  • Integrins (metabolism)
  • Plasminogen Activator Inhibitor 1 (physiology)
  • Receptors, Vitronectin (metabolism)
  • Urokinase-Type Plasminogen Activator (physiology)
  • Vitronectin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: